CNR Institutional Research Information System

Mallamaci, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.443
NA - Nord America 1.519
EU - Europa 880
SA - Sud America 703
AF - Africa 70
OC - Oceania 6
Totale 6.621
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.502
US - Stati Uniti d'America 1.438
CN - Cina 790
BR - Brasile 564
VN - Vietnam 347
HK - Hong Kong 343
IT - Italia 321
FR - Francia 202
KR - Corea 129
JP - Giappone 75
GB - Regno Unito 58
DE - Germania 57
BD - Bangladesh 56
FI - Finlandia 53
AR - Argentina 52
IN - India 49
NL - Olanda 42
CA - Canada 34
EC - Ecuador 25
ID - Indonesia 24
MX - Messico 23
ZA - Sudafrica 20
IL - Israele 19
IQ - Iraq 17
UA - Ucraina 17
MA - Marocco 16
CO - Colombia 15
ES - Italia 15
IE - Irlanda 15
RU - Federazione Russa 15
PL - Polonia 13
AT - Austria 12
PY - Paraguay 11
SA - Arabia Saudita 11
TR - Turchia 11
UY - Uruguay 11
VE - Venezuela 11
PK - Pakistan 9
SE - Svezia 9
AE - Emirati Arabi Uniti 7
EG - Egitto 7
PE - Perù 7
AL - Albania 6
CR - Costa Rica 6
KG - Kirghizistan 6
UZ - Uzbekistan 6
DZ - Algeria 5
HU - Ungheria 5
JO - Giordania 5
MY - Malesia 5
NP - Nepal 5
TN - Tunisia 5
AZ - Azerbaigian 4
BO - Bolivia 4
GR - Grecia 4
HR - Croazia 4
LT - Lituania 4
NI - Nicaragua 4
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
KE - Kenya 3
NZ - Nuova Zelanda 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BY - Bielorussia 2
DJ - Gibuti 2
EE - Estonia 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
PA - Panama 2
PH - Filippine 2
SI - Slovenia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
Totale 6.605
Salva come PNG Salva come JPEG
Città #
Singapore 938
Santa Clara 405
Hong Kong 340
Hefei 276
San Jose 185
Lauterbourg 166
Beijing 156
Seoul 129
Ho Chi Minh City 125
Ashburn 109
Los Angeles 92
Hanoi 89
Dallas 58
New York 56
Tokyo 50
São Paulo 41
Frankfurt am Main 25
Buffalo 24
Lappeenranta 24
Helsinki 19
Milan 18
Minamishinagawa 18
Rome 17
Rio de Janeiro 16
Council Bluffs 15
Orem 15
Amsterdam 14
Da Nang 14
Dublin 14
Haiphong 14
Curitiba 13
Bengaluru 12
Warsaw 12
Belo Horizonte 11
Brooklyn 11
London 11
Houston 10
Johannesburg 10
Quito 10
Thái Bình 10
Biên Hòa 9
Brasília 9
Catania 9
Montevideo 9
Portsmouth 9
Turku 9
Düsseldorf 8
Guayaquil 8
Montreal 8
Porto Alegre 8
Stockholm 8
Vienna 8
Bologna 7
Denver 7
Munich 7
Salvador 7
Bari 6
Bishkek 6
Campinas 6
Chicago 6
Dhaka 6
Guarulhos 6
Lima 6
Mexico City 6
Mumbai 6
Newark 6
Pisa 6
San Francisco 6
Tashkent 6
Amman 5
Baghdad 5
Charlotte 5
City of London 5
Falerna 5
Falkenstein 5
Florianópolis 5
Ha Long 5
Phoenix 5
San José 5
Toronto 5
Atlanta 4
Baku 4
Bogotá 4
Buenos Aires 4
Campos dos Goytacazes 4
Cape Town 4
Chennai 4
Contagem 4
Hải Dương 4
Juiz de Fora 4
Kyiv 4
Londrina 4
Madrid 4
Naples 4
New Delhi 4
Nova Iguaçu 4
Osasco 4
Paris 4
Philadelphia 4
Pouso Alegre 4
Totale 3.915
Salva come PNG Salva come JPEG
Nome #
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study 103
The long-term effect of a lung-ultrasound intervention on the risk for death, heart failure and myocardial infarction in dialysis patients 94
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 92
Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis 84
Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension 83
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study 78
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study 77
Osteopontin, death and cardiovascular events in stage G3–4 CKD patients: a joint model analysis 76
Neuropeptide y gene polymorphisms and chronic kidney disease progression 72
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study 70
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes 70
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients 69
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 68
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 68
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 68
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis 67
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 66
Long-Term Effect of Physical Exercise on the Risk for Hospitalization and Death in Dialysis Patients A Post-Trial Long-Term Observational Study 65
Socioeconomic Status and Clinical Outcomes in Chronic Kidney Disease: Bootstrap Validation of a Simple Indicator 65
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 65
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension 62
Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease 61
Osteopontin and Clinical Outcomes in Hemodialysis Patients 61
A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk 61
Phosphate and the renoprotective effect of ace inhibition: a post-hoc analysis of the Rein Trial. 60
Physical activity and exercise in chronic kidney disease: consensus statements from the Physical Exercise Working Group of the Italian Society of Nephrology 60
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients 58
Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients 58
Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients? 57
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 56
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 55
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease 55
Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension 54
The bidirectional link between left ventricular hypertrophy and chronic kidney disease. A cross lagged analysis 53
Sleep-Disordered Breathing and 24-Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study 53
Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease 53
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 53
Long-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI 53
Can the assessment of ultrasound lung water in haemodialysis patients be simplified? 53
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 52
CKD-MBD biomarkers and CKD progression: an analysis by the joint model 52
Adiponectin and Leptin in chronic kidney disease: causal factors or mere risk markers? 51
Valore prognostico delle formule di dtims del FG nella popolazione di pazienti con MRC dello studio MAURO. 50
Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients 50
Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model 50
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 50
Shedding a light on sex disparity in clinical trials in CKD patients 49
Hypertension management in chronic kidney disease 49
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 49
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 47
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 47
Biomarkers in clinical epidemiology studies 47
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 47
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 47
Prognostic values of left ventricular mass index in chronic kidney disease patients 47
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 47
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 46
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 46
FGF23 and the PTH response to paricalcitol in chronic kidney disease 46
Endogenous opioid antagonism and the insulin response to oral glucose load in kidney failure patients: a randomized clinical trial 45
Quality of life and kidney function in CKD patients: a longitudinal study 45
Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. 44
Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity-An Italian Study 44
Fluid overload trajectories and mortality in hemodialysis patients 43
Physical activity in chronic kidney disease and the EXerCise Introduction To Enhance trial 43
Decoy receptors as biomarkers for exploring aetiology and designing new therapies 43
Obesity and the epidemiology and prevention of kidney disease: waist circumference versus body mass index. 42
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 42
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 42
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 41
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 41
Neuropeptide Y and chronic kidney disease progression: a cohort study 41
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts 39
Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population 39
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 39
Long term predictors of cerebrovascular events in patients with end stage renal disease (ESRD). 38
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 37
Lung ultrasound to detect and monitor pulmonary congestion in patients with acute kidney injury in nephrology wards: a pilot study 36
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 36
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 36
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 36
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. 34
EARLY MORNING HEMODYNAMIC CHANGES AND LEFT VENTRICULAR HYPERTROPHY AND MORTALITY IN HEMODIALYSIS PATIENTS 34
Fitness for Entering a Simple Exercise Program and Mortality: A Study Corollary to the Exercise Introduction to Enhance Performance in Dialysis (Excite) Trial 33
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial 32
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 32
Vitamin D Receptor (VDR) gene polymorphism is associated with Left Ventricular (LV) mass and predicts Left Ventricular Hypertrophy (LVH) progression in End-Stage Renal Disease (ESRD) patients 32
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 32
La E-selettina è un marker di rischio e interagisce con la flogosi nei pazienti in dialisi. 31
Joint effect of insulin signaling genes on all-cause mortality 31
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 31
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease 31
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 30
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. 30
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 30
Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study. 30
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 30
Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. 29
Biomarcatori del volume atriale sinistro: uno studio longitudinale nei pazienti in dialisi. 29
Totale 5.038
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.407
article - articoli 17.048
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 432
Totale 40.887
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202496 0 0 0 0 0 0 0 0 56 15 24 1
2024/20252.782 18 15 213 192 537 58 110 208 99 86 702 544
2025/20264.100 233 423 405 554 765 132 635 253 231 300 169 0
Totale 6.978